BrainAurora Medical Technology Limited (6681) Stock Statistics & Valuation Metrics

BrainAurora Medical Technology Limited has a market cap or net worth of HK$1.62B. The enterprise value is HK$1.83B.

BrainAurora Medical Technology Limited has 1,358,278,000 shares outstanding. The number of shares has decreased by -2.65% in one year.

BrainAurora Medical Technology Limited’s return on equity (ROE) is -3.23 and return on invested capital (ROIC) is -43.90%.

The current PE Ratio of BrainAurora Medical Technology Limited is ―. BrainAurora Medical Technology Limited’s PEG ratio is -0.94.

In the last 12 months, BrainAurora Medical Technology Limited had revenue of 220.05M and earned -314.86M in profits. Earnings per share was -0.27.

In the last 12 months, operating cash flow was -67.88M and capital expenditures -6.79M, giving a free cash flow of -74.67M billion.

BrainAurora Medical Technology Limited pays an annual dividend of ―, resulting in a dividend yield of ―

BrainAurora Medical Technology Limited upcoming earnings date is Mar 26, 2027, Before Open (Not Confirmed).

BrainAurora Medical Technology Limited as a current ratio of 1.56, with Debt / Equity ratio of 132.65%

In the past 12 months, BrainAurora Medical Technology Limited has paid 100.00K in taxes.

BrainAurora Medical Technology Limited EV to EBITDA ratio is -26.38, with an EV/FCF ratio of -33.95.

BrainAurora Medical Technology Limited has HK$658.44M in cash and marketable securities with HK$556.24M in debt, giving a net cash position of HK$102.20M billion.

Gross margin is 43.03%, with operating margin of -132.22%, and net profit margin of -143.09%.

The average price target for BrainAurora Medical Technology Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―